Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice

Journal of Clinical Investigation

Volumn 103, Issue 7, 1999, Pages 1031-1038

  Jacobson, Leslie ^a,c   Polizzi, Agata ^a,d   Morriss Kay, Gillian ^b   Vincent, Angela ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY;

ANIMAL CELL; ARTHROGRYPOSIS; ARTICLE; CONGENITAL MALFORMATION; DISEASE SEVERITY; FETUS DEATH; FETUS DEVELOPMENT; FETUS MALFORMATION; JOINT CONTRACTURE; MATERNAL BLOOD; MOUSE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; VERTICAL TRANSMISSION;

EID: 0032924923     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5943     Document Type: Article

References (38)

1. Hall, J.G. 1996. Arthrogryposes: multiple congenital contractures. In Principles of medical genetics. D.L. Rimoin, J.M. Connor, and R.E. Pyeritz, editors. Churchill Livingstone. New York, NY. 2869-2915.
2. Porter, H.J. 1995. Lethal arthrogryposis multiplex congenita (fetal akinesia deformation sequence, FADS). Pediatr. Pathol. Lab. Med. 15:617-637.
3. Dastur, D., Rassak, Z., and Bharucha, E. 1972. Arthrogryposis multiplex congenita. Part 2: Muscle pathology and pathogenesis. J. Neurol. Neurosurg. Psychiatry. 35:435-450.
4. Banker, B. 1985. Neuropathologic aspects of arthrogryposis multiplex congenita. Clin. Orthop. 194:30-43.
5. Drachman, D.B. and Coulombre, A. 1962. Experimental clubfoot and arthrogryposis multiplex congenita. Lancet. 2:523-526.
6. Moessinger, A. 1983. Fetal akinesia deformation sequence: an animal model. Pediatrics. 72:857-863.
7. Jago, R.H. 1970. Arthrogryposis following treatment of maternal tetanus with muscle relaxants. Arch. Dis. Child. 45:277-279.
8. Vincent, A., et al. 1995. Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet. 346:24-25.
9. Riemersma, S., et al. 1997. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J. Clin. Invest. 98:2358-2363.
10. Pena, S.D.J., and Shokeir, M.H.K. 1974. Syndrome of camptodactyly, multiple ankyloses, facial anomalies and pulmonary hypoplasia: a lethal condition. J. Pediatr. 85:373.
11. Drachman, D.B. 1994. Myasthenia gravis. New Eng. J. Med. 330:1797-1810.
12. Venet-der Garabedian, B., et al. 1994. Association of neonatal myasthenia gravis with antibodies against the foetal acetylcholine receptor. J. Clin. Invest. 94:555-559.
13. Eymard, B. 1997. Neonatal myasthenia gravis clinical and pathophysiological aspects. Adv. Organ Biol. 2:235-247.
14. Barnes, P.R.J., et al. 1995. Recurrent congenital arthrogryposis leading to a diagnosis of myasthenia gravis in an initially asymptomatic mother. Neuromuscul. Disord. 5:55-65.
15. Hesselmans, L., Jennekens, F., van den Oord, C., Veldman, H., and Vincent, A. 1993. Immunoreactivity to the acetylcholine receptor in developing human muscle. Anat. Rec. 236:553-562.
16. Gluecksohn-Waelsch, S. 1957. The effect of maternal immunization against organ tissues on embryonic differentiation in the mouse. J. Embryol. Exp. Morphol. 5:83-92.
17. Adinolfi, M. 1993. Fetal exposure to maternal brain antibodies and neurological handicap. In Dyslexia and development. A.M. Galaburda, editor. Harvard University Press. Cambridge, MA. 155-167.
18. Vincent, A., Jacobson, L., and A. Polizzi. 1997. An animal model for arthrogyrposis multiplex congenita caused by antibodies to fetal acetylcholine receptor. Ann. Neurol. 42:391A. (Abstr.)
19. Jacobson, L., Beeson, A., and Vincent, A. 1998. An animal model of maternal antibody-mediated arthrogryposis multiplex congenita. Ann. NY Acad. Sci. 841:565-567.
20. Beeson, D., Jacobson, L., Newsom-Davis, J., and Vincent, A. 1996. A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis. Neurology. 47:1552-1555.
21. Toyka, K.V, et al. 1977. Myasthenia gravis: study of humoral immune mechanisms by passive transfer to mice. New Engl. J. Med. 296:125-131.
22. Mossman, S., Vincent, A. and Newsom-Davis, J. 1988. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between antibody bound, acetylcholine receptor loss and transmission defect. J. Neurol. Sci. 84:15-28.
23. Vincent, A. 1997. Disorders of the human neuromuscular junction. Adv. Organ Biol. 2:315-349.
24. Dinger, J., and Prager, B. 1993. Arthrogryposis multiplex in a newborn of a myasthenic mother - case report and literature. Neuromuscul Disord. 3:335-339.
25. Simister, N.B. and Story, C.M. 1997. Human placental Fc receptors and the transmission of antibodies from mother to fetus. J. Reprod. Immunol. 37:1-23.
26. Ghetie, V., and Ward, E.S. 1997. FcRn: the MHC class I-related receptor that is more than an IgG transporter. Immunol. Today. 18:592-598.
27. Blank, M, Cohen, J., Toder, V., and Shoenfeld, Y. 1991. Induction of antiphospholipid syndrome in naïve mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc. Natl. Acad. Sci. USA. 88:3069-3073.
28. Shoenfeld, Y., Sherer, Y., and Blank, M. 1998. Antiphospholipid antibodies in pregnancy. Scand. J. Rheumatol. Suppl. 107:33-36.
29. Guzman-Enriquez, L., Avalos-Diaz, E., and Herrera-Esparza, R. 1990. Transplacental transfer of human antinuclear antibodies in mice by injection of Lupus IgG in regnant animals. J. Rheumatol. 17:52-56.
30. Gottvall, T., Hilden, J.O., Nelson, N., and Filbey, D. 1995. Severe RhD immunization: anti-D quantitation and treatment possibilities during pregnancy and after birth. Acta Paediatr. 84:1315-1317.
31. Deka, D., Buckshee, K., and Kinra, G. 1996. Intravenous immunoglobulin as primary therapy or adjuvant therapy to intrauterine fetal blood transfusion; a new approach in the management of severe Rh immunisation. J. Obstet. Gynaecol. Res. 22:561-567.
32. Porcelign, L., and Kanhai, H.H. 1988. Fetal thrombocytopenia. Curr. Opin. Obstet. Gynecol. 10:117-122.
33. Chameides, L., et al. 1977. Association of maternal system lupus erythematosus with congenital complete heart block. New Engl. J. Med. 297:1204-1207.
34. Olson, N.Y., and Lindsey, C.B. 1987. Neonatal lupus syndrome. Am. J. Dis. Child. 141:908-910.
35. Carr, S.R., Gilchrist, J.M., Abuelo, D.N. and Clark, D. 1991. Treatment of antenatal Myasthenia Gravis. Obstet. Gynecol. 78:485-489.
36. Urbaniak, S.J., Duncan, J.I., Armstrong-Fisher, S.S. Abramovich, D.R., and Page, K.R. 1997. Transfer of anti-D antibodies across the isolated perfused human placental lobule and inhibition by high dose intravenous immunoglobulin: a possible mechanism of action. Br. J. Haematol. 98:493-494.
37. Denenberg, V.H., et al. 1991. Effects of the autoimmune uterine/maternal environment upon cortical ectopias, behaviour and autoimmunity. Brain Res. 563:114-122.
38. Ziporen, L., Shoenfeld, Y., Levy, Y., and Korczyn, A.D. 1997. Neurological dysfunction and hyperactive behaviour associated with antiphospholipid antibodies. A mouse model. J. Clin. Invest. 100:613-619.